Variations in polyamine concentration are observed in case of neurodegenerative illness. Theantimalarial quinacrine is an alkylating agent characterised by the presence of an aliphatic chainsimilar to that of putrescine and spermine, two polyamines whose activation is closely associatedwith cell proliferation. Airn of the present study was the evaluation of the effect of quinacrine andpolyamines, alone and in combination, on glioblastomas cell replication. Methods: Humanglioblastomas cells (U87-MG) were cultured in EMEM (+37"C in 5% COL in air) and treated withincreasing concentrations of quinacrine (from 3.3 microM to 100 microM), putrescine (from 0.05 microM to 0.5microM), spermine ( from 0.5 microM to 10 microM) and quinacrine plus putrescine or spermine. Results FomMTT test showed that putrescine and spermine 0.5 microM significantly stimulate U87-MG cell growth(+53.86% and + 28% respectively), whereas quinacrine confirmed to be a potent cell inhibitor. Thecombination of sub-inhibitory concentrations of quinacrine (34 microM) plus putrescine (0.5 microM)resulted in a significant inhibition (-63%) of cell replication, but the same inhibitory effect (-26%)was reached using a lower concentration of quinacrine (17microM). The same results (- 64.57% and -28%) were obtained fiom the combination quinacrine (34 microM)/spermine (0.5 microM) and quinacrine(17microM)/spermine (0.5 microM). Preliminary results from the western blotting test performed on U87-MG cells indicate that the bcl-2 expression seems to be reduced in the cultures treated with thecombiitions polyamine/quinacrine (34 microM) Conclusion: Natural polyamines putrescine andspermine added to U87-MG cell cultures significantly stimulate cell growth. Quinacrine lowconcentration (17microM) antagonises cell proliferation induced by the polyamines. We suppose thatthe presence of the aliphatic chain both in quinacrine and in polyamines could be at the basis of thisinteraction. If our hypothesis will be confirmed, it will be possible to postulate the use of lowconcentrations of quinacrine in the treatment of neurodegenerative illness or malignancies inducedby variations in polyamine levels in human brain.
Attenzione! Scheda prodotto non ancora validata dall'Ateneo
|Data di pubblicazione:||2007|
|Titolo:||POTENTIAL ROLE OF THE ANTIMALARIAL QUINACRINE AS ANTIPROLIFERATIVE AGENT IN NEURODEGENERATIVE ILLNESS|
|Autori:||A.COPPI; G. BAGGIO; E. BRUNI; T.ROSSI|
|Autori interni:||BAGGIO, Giosuè Gabriele |
|Data del convegno:||19-20 febbraio 2007|
|Nome del convegno:||COST ACTION B22 DRUG DEVELOPFOR PARASITIC DIS|
|Luogo del convegno:||Modena|
|Titolo del libro:||MEDICINAL CHEMISTRY IN PARASITOLOGY: NEW AVENUES IN DRUG DISCOVERY|
|Appare nelle tipologie:||Relazione in Atti di Convegno|
File in questo prodotto:
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris